Connection

Rozemarijn Vliegenthart to Early Detection of Cancer

Back to Details
This is a "connection" page, showing publications Rozemarijn Vliegenthart has written about Early Detection of Cancer.
Rozemarijn Vliegenthart
Connection Strength
4.019
Early Detection of Cancer
  1. Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population: rationale and design of the ImaLife (Imaging in Lifelines) Study. Eur J Epidemiol. 2020 Jan; 35(1):75-86.
    View in: PubMed
    Score: 0.454
  2. The impact of radiologists' expertise on screen results decisions in a CT lung cancer screening trial. Eur Radiol. 2015 Mar; 25(3):792-9.
    View in: PubMed
    Score: 0.333
  3. A practical approach to radiological evaluation of CT lung cancer screening examinations. Cancer Imaging. 2013 Sep 23; 13(3):391-9.
    View in: PubMed
    Score: 0.308
  4. Innovations in thoracic imaging: CT, radiomics, AI and x-ray velocimetry. Respirology. 2022 10; 27(10):818-833.
    View in: PubMed
    Score: 0.143
  5. Community-based lung cancer screening by low-dose computed tomography in China: First round results and a meta-analysis. Eur J Radiol. 2021 Nov; 144:109988.
    View in: PubMed
    Score: 0.134
  6. Seasonal prevalence and characteristics of low-dose CT detected lung nodules in a general Dutch population. Sci Rep. 2021 04 28; 11(1):9139.
    View in: PubMed
    Score: 0.130
  7. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020 02 06; 382(6):503-513.
    View in: PubMed
    Score: 0.120
  8. Screening for Early Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease (the Big-3) Using Low-dose Chest Computed Tomography: Current Evidence and Technical Considerations. J Thorac Imaging. 2019 May; 34(3):160-169.
    View in: PubMed
    Score: 0.114
  9. An Update on the European Lung Cancer Screening Trials and Comparison of Lung Cancer Screening Recommendations in Europe. J Thorac Imaging. 2019 Jan; 34(1):65-71.
    View in: PubMed
    Score: 0.111
  10. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study. Thorax. 2019 03; 74(3):247-253.
    View in: PubMed
    Score: 0.111
  11. Low-dose CT for lung cancer screening - Authors' reply. Lancet Oncol. 2018 03; 19(3):e135-e136.
    View in: PubMed
    Score: 0.105
  12. European position statement on lung cancer screening. Lancet Oncol. 2017 12; 18(12):e754-e766.
    View in: PubMed
    Score: 0.103
  13. Management of Progressive Pulmonary Nodules Found?during and outside of CT Lung Cancer Screening Studies. J Thorac Oncol. 2017 12; 12(12):1755-1765.
    View in: PubMed
    Score: 0.102
  14. Public Preferences for Lung Cancer Screening Policies. Value Health. 2017 Jul - Aug; 20(7):961-968.
    View in: PubMed
    Score: 0.099
  15. Risk stratification based on screening history: the NELSON lung cancer screening study. Thorax. 2017 09; 72(9):819-824.
    View in: PubMed
    Score: 0.098
  16. Quantification of growth patterns of screen-detected lung cancers: The NELSON study. Lung Cancer. 2017 06; 108:48-54.
    View in: PubMed
    Score: 0.098
  17. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval. Thorax. 2017 01; 72(1):48-56.
    View in: PubMed
    Score: 0.093
  18. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol. 2016 Jul; 17(7):907-916.
    View in: PubMed
    Score: 0.093
  19. Prognostic value of heart valve calcifications for cardiovascular events in a lung cancer screening population. Int J Cardiovasc Imaging. 2015 Aug; 31(6):1243-9.
    View in: PubMed
    Score: 0.086
  20. Contributions of the European trials (European randomized screening group) in computed tomography lung cancer screening. J Thorac Imaging. 2015 Mar; 30(2):101-7.
    View in: PubMed
    Score: 0.085
  21. Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules? Eur Respir J. 2015 Mar; 45(3):765-73.
    View in: PubMed
    Score: 0.084
  22. Interscan variation of semi-automated volumetry of subsolid pulmonary nodules. Eur Radiol. 2015 Apr; 25(4):1040-7.
    View in: PubMed
    Score: 0.083
  23. Association of chronic obstructive pulmonary disease and smoking status with bone density and vertebral fractures in male lung cancer screening participants. J Bone Miner Res. 2014 Oct; 29(10):2224-9.
    View in: PubMed
    Score: 0.083
  24. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol. 2014 Nov; 15(12):1342-50.
    View in: PubMed
    Score: 0.083
  25. Pulmonary function and CT biomarkers as risk factors for cardiovascular events in male lung cancer screening participants: the NELSON study. Eur Radiol. 2015 Jan; 25(1):65-71.
    View in: PubMed
    Score: 0.082
  26. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals. Eur Radiol. 2013 Jul; 23(7):1836-45.
    View in: PubMed
    Score: 0.074
  27. Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations. Pharmacoeconomics. 2023 Apr; 41(4):395-411.
    View in: PubMed
    Score: 0.037
  28. Lung cancer screening. Lancet. 2023 02 04; 401(10374):390-408.
    View in: PubMed
    Score: 0.037
  29. Association between visual emphysema and lung nodules on low-dose CT scan in a Chinese Lung Cancer Screening Program (Nelcin-B3). Eur Radiol. 2022 Dec; 32(12):8162-8170.
    View in: PubMed
    Score: 0.035
  30. Lung cancer screening with low-dose CT: Simulating the effect of starting screening at a younger age in women. Eur J Radiol. 2022 Mar; 148:110182.
    View in: PubMed
    Score: 0.034
  31. Deep Learning Reconstruction Shows Better Lung Nodule Detection for Ultra-Low-Dose Chest CT. Radiology. 2022 04; 303(1):202-212.
    View in: PubMed
    Score: 0.034
  32. Can we increase efficiency of CT lung cancer screening by combining with CVD and COPD screening? Results of an early economic evaluation. Eur Radiol. 2022 May; 32(5):3067-3075.
    View in: PubMed
    Score: 0.034
  33. Creating a training set for artificial intelligence from initial segmentations of airways. Eur Radiol Exp. 2021 11 29; 5(1):54.
    View in: PubMed
    Score: 0.034
  34. Performance of a deep learning-based lung nodule detection system as an alternative reader in a Chinese lung cancer screening program. Eur J Radiol. 2022 Jan; 146:110068.
    View in: PubMed
    Score: 0.034
  35. Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai: Rationale and Design of a Population-based Comparative Study. Acad Radiol. 2021 01; 28(1):36-45.
    View in: PubMed
    Score: 0.030
  36. New Fissure-Attached Nodules in Lung Cancer Screening: A Brief Report From The NELSON Study. J Thorac Oncol. 2020 01; 15(1):125-129.
    View in: PubMed
    Score: 0.029
  37. Assessing Lung Cancer Screening Programs under Uncertainty in a Heterogeneous Population. Value Health. 2018 11; 21(11):1269-1277.
    View in: PubMed
    Score: 0.027
  38. New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial. J Thorac Oncol. 2018 09; 13(9):1410-1414.
    View in: PubMed
    Score: 0.027
  39. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study. Lung Cancer. 2018 11; 125:103-108.
    View in: PubMed
    Score: 0.027
  40. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study. Thorax. 2018 08; 73(8):741-747.
    View in: PubMed
    Score: 0.026
  41. Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening. Thorax. 2018 08; 73(8):779-781.
    View in: PubMed
    Score: 0.026
  42. Detection and size measurements of pulmonary nodules in ultra-low-dose CT with iterative reconstruction compared to low dose CT. Eur J Radiol. 2016 Mar; 85(3):564-70.
    View in: PubMed
    Score: 0.022
  43. Quantification of coronary artery calcium in nongated CT to predict cardiovascular events in male lung cancer screening participants: results of the NELSON study. J Cardiovasc Comput Tomogr. 2015 Jan-Feb; 9(1):50-7.
    View in: PubMed
    Score: 0.021
  44. Computed tomographic characteristics of interval and post screen carcinomas in lung cancer screening. Eur Radiol. 2015 Jan; 25(1):81-8.
    View in: PubMed
    Score: 0.021
  45. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations. Acta Radiol. 2014 Jul; 55(6):691-8.
    View in: PubMed
    Score: 0.019
  46. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J. 2013 Dec; 42(6):1659-67.
    View in: PubMed
    Score: 0.019
  47. Impact of cardiovascular calcifications on the detrimental effect of continued smoking on cardiovascular risk in male lung cancer screening participants. PLoS One. 2013; 8(6):e66484.
    View in: PubMed
    Score: 0.019
  48. Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening. Respir Res. 2013 May 27; 14:59.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.